SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Aug-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 20-Aug-24 | Payment of Exercise | 572 | $29.57 | $16,914.00 | (6%) 10.25K to 9.68K | |
20-Aug-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 20-Aug-24 | Option Exercise | 1,250 | -- | -- | 14% 9.0K to 10.25K | |
25-Mar-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 21-Mar-24 | Option Exercise | 14,491 | $25.30 | $366,622.00 | 169% 8.57K to 23.06K | |
25-Mar-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 21-Mar-24 | Planned Option Sale | 14,491 | $35.31 | $511,677.00 | (63%) 23.06K to 8.57K | |
22-Mar-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 20-Mar-24 | Option Exercise | 400 | $25.30 | $10,120.00 | 5% 8.57K to 8.97K | |
22-Mar-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 20-Mar-24 | Planned Option Sale | 400 | $35.31 | $14,124.00 | (4%) 8.97K to 8.57K | |
21-Mar-24 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 19-Mar-24 | Option Exercise | 12,364 | $25.30 | $312,809.00 | 144% 8.57K to 20.93K | |
21-Mar-24 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 19-Mar-24 | Planned Option Sale | 12,364 | $35.31 | $436,573.00 | (59%) 20.93K to 8.57K | |
15-Mar-24 6:39 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 13-Mar-24 | Option Exercise | 62,366 | $17.61 | $1,098,520.00 | 728% 8.57K to 70.94K | |
15-Mar-24 6:39 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 13-Mar-24 | Planned Option Sale | 62,366 | $33.74 | $2,104,290.00 | (88%) 70.94K to 8.57K | |
14-Mar-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 12-Mar-24 | Option Exercise | 3,884 | $12.98 | $50,414.30 | 45% 8.57K to 12.45K | |
14-Mar-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 12-Mar-24 | Planned Option Sale | 3,884 | $32.99 | $128,133.00 | (31%) 12.45K to 8.57K | |
28-Feb-24 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 26-Feb-24 | Option Exercise | 5,000 | $9.13 | $45,650.00 | 58% 8.57K to 13.57K | |
28-Feb-24 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 26-Feb-24 | Planned Option Sale | 5,000 | $30.21 | $151,050.00 | (37%) 13.57K to 8.57K | |
27-Feb-24 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 23-Feb-24 | Grant | 1,250 | -- | -- | 16% 7.96K to 9.21K | |
27-Feb-24 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 23-Feb-24 | Payment of Exercise | 638 | $29.06 | $18,540.30 | (7%) 9.21K to 8.57K | |
26-Feb-24 5:02 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-24 | Grant | 750 | -- | -- | 10% 7.58K to 8.33K | |
26-Feb-24 5:02 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-24 | Payment of Exercise | 372 | $27.94 | $10,393.70 | (4%) 8.33K to 7.96K | |
07-Sep-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 07-Sep-23 | Payment of Exercise | 1,182 | $32.10 | $37,942.20 | (14%) 8.35K to 7.17K | |
07-Sep-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 07-Sep-23 | Option Exercise | 2,500 | -- | -- | 43% 5.85K to 8.35K | |
12-May-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 11-May-23 | Option Exercise | 750 | -- | -- | 16% 4.75K to 5.5K | |
12-Apr-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 11-Apr-23 | Grant | 1,500 | -- | -- | 46% 3.25K to 4.75K | |
24-Feb-23 5:06 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-23 | Grant | 750 | -- | -- | 30% 2.5K to 3.25K | |
19-Jan-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 17-Jan-23 | Option Exercise | 4,826 | $9.13 | $44,061.40 | 294% 1.64K to 6.47K | |
19-Jan-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 17-Jan-23 | Planned Option Sale | 4,826 | $39.92 | $192,638.00 | (75%) 6.47K to 1.64K | |
09-Jan-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 06-Jan-23 | Option Exercise | 174 | $9.13 | $1,588.62 | 11% 1.64K to 1.82K | |
09-Jan-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 06-Jan-23 | Planned Option Sale | 174 | $39.90 | $6,942.60 | (10%) 1.82K to 1.64K | |
02-Dec-22 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 01-Dec-22 | Option Exercise | 5,000 | $9.13 | $45,650.00 | 304% 1.64K to 6.64K | |
02-Dec-22 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 01-Dec-22 | Planned Option Sale | 5,000 | $37.48 | $187,416.00 | (75%) 6.64K to 1.64K | |
15-Nov-22 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 11-Nov-22 | Option Exercise | 6,800 | $9.24 | $62,832.00 | 414% 1.64K to 8.44K | |
15-Nov-22 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 11-Nov-22 | Planned Option Sale | 6,800 | $34.95 | $237,655.00 | (81%) 8.44K to 1.64K | |
14-Nov-22 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 09-Nov-22 | Option Exercise | 700 | $9.24 | $6,468.00 | 43% 1.64K to 2.34K | |
14-Nov-22 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 09-Nov-22 | Planned Option Sale | 700 | $34.97 | $24,479.90 | (30%) 2.34K to 1.64K | |
05-Aug-22 4:31 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 15-Jul-22 | Grant | 750 | -- | -- | 84% 0.89K to 1.64K | |
29-Jun-18 6:03 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 29-Jun-18 | Market Sale | 4,393 | $59.90 | $263,153.00 | (100%) 4.39K to 0 | 55% |
29-Jun-18 6:03 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 28-Jun-18 | Option Exercise | 295 | $9.13 | $2,693.35 | 4% 7.5K to 7.79K | |
29-Jun-18 6:03 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 28-Jun-18 | Market Option Sale (Planned) | 295 | $59.94 | $17,680.90 | (4%) 7.79K to 7.5K | 55% |
29-Jun-18 6:03 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 28-Jun-18 | Market Sale (Planned) | 3,107 | $59.94 | $186,218.00 | (41%) 7.5K to 4.39K | 55% |
22-Jun-18 5:30 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 21-Jun-18 | Option Exercise | 7,205 | $9.13 | $65,781.60 | 96% 7.5K to 14.71K | |
22-Jun-18 5:30 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 21-Jun-18 | Market Option Sale (Planned) | 7,205 | $60.00 | $432,323.00 | (49%) 14.71K to 7.5K | 55% |
16-May-18 5:05 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 15-May-18 | Option Exercise | 7,868 | $9.14 | $71,875.30 | 105% 7.5K to 15.37K | |
16-May-18 5:05 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 15-May-18 | Market Option Sale (Planned) | 7,868 | $57.93 | $455,759.00 | (51%) 15.37K to 7.5K | 54% |
14-May-18 3:09 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 11-May-18 | Option Exercise | 42,132 | $8.60 | $362,500.00 | 337% 12.5K to 54.63K | |
14-May-18 3:09 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 11-May-18 | Market Option Sale (Planned) | 42,132 | $54.49 | $2,295,720.00 | (77%) 54.63K to 12.5K | 51% |
14-May-18 3:09 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 11-May-18 | Market Sale (Planned) | 5,000 | $54.49 | $272,444.00 | (40%) 12.5K to 7.5K | 51% |
14-May-18 3:09 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 10-May-18 | Option Exercise | 20,000 | $7.90 | $158,000.00 | 160% 12.5K to 32.5K | |
14-May-18 3:09 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 10-May-18 | Market Option Sale (Planned) | 20,000 | $49.88 | $997,544.00 | (62%) 32.5K to 12.5K | 46% |
22-Jan-18 8:43 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Jan-18 | Option Exercise | 20,000 | $7.90 | $158,000.00 | 160% 12.5K to 32.5K | |
22-Jan-18 8:43 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Jan-18 | Market Option Sale (Planned) | 20,000 | $48.04 | $960,716.00 | (62%) 32.5K to 12.5K | 44% |
17-Jan-18 6:38 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 17-Jan-18 | Option Exercise | 20,000 | $7.90 | $158,000.00 | 160% 12.5K to 32.5K |